Ensacove Capsule
Product Images NDC 83076-1100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ensacove (NDC 83076-1100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xcovery Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ensacove 1)

Chemical Structure (Ensacove 1)
Chemical structure of ensartinib, the active ingredient in ENSACOVE capsules. The diagram shows the molecular arrangement including fluorine, chlorine, nitrogen, oxygen, and other elements relevant to the compound's chemical composition.*
FDA Label Image

Figure 1 (Ensacove 2)

Figure 1 (Ensacove 2)
A Kaplan-Meier survival curve comparing progression-free survival (%) over time in months for ENSACOVE (ensartinib) and Crizotinib. The solid line represents ENSACOVE and the dashed line represents Crizotinib, with censored data points marked. A table below shows the number of patients at risk for each treatment group at various time points.*
FDA Label Image

25 mg Bottle Label (Ensacove 3)

25 mg Bottle Label (Ensacove 3)
ENSACOVE 25 mg capsules label showing the product name, generic name ensartinib, dosage strength of 25 mg per capsule, and package size of 30 capsules. The label includes storage instructions, distributor information (Xcovery Holdings, Inc.), and a barcode. It indicates Rx Only status and advises referring to prescribing information for dosage.*
FDA Label Image

25mg Carton Label (Ensacove 4)

25mg Carton Label (Ensacove 4)
ENSACOVE 25 mg capsules packaging label showing the drug name and strength prominently on the front panels. The label states ensartinib as the active ingredient, with storage instructions and handling cautions. The carton contains 30 capsules and is labeled for prescription use only, distributed by Xcovery Holdings, Inc., Miami, FL. Barcodes and expiry placeholders are also visible.*
FDA Label Image

100 mg Bottle Label (Ensacove 5)

100 mg Bottle Label (Ensacove 5)
ENSACOVE 100 mg capsules (ensartinib) label for oral use, containing 60 capsules. The label indicates prescription use only, with storage instructions and distributor information for Xcovery Holdings, Inc. The NDC is 83076-1100-6.*
FDA Label Image

100mg Carton Label (Ensacove 6)

100mg Carton Label (Ensacove 6)
Packaging label for ENSACOVE (ensartinib) capsules 100 mg by Xcovery Holdings, Inc. The label indicates 60 capsules per bottle with recommended storage at controlled room temperature. The label includes NDC 83076-1100-6 and displays storage instructions, dosage note, and a barcode. The design features orange and white background with product and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.